Top Markets
#1 Useless Coin Useless Coin +40.04%
#2 Merlin's Seal BTC Merlin's Seal BTC +37.79%
#3 StonkBroker StonkBroker +36.44%
#4 0G 0G +35.41%
#5 SAFEcoin SAFEcoin +28.81%
#6 Arbitrum Arbitrum +19.69%
#7 Zora Zora +19.48%
#8 Dogs Dogs +18.55%
#9 Full Moon Full Moon +18.06%
#10 Notcoin Notcoin +18.00%
Coin of the day
Useless Coin Useless Coin
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Komipharm International Co., Ltd. Komipharm International Co., Ltd.

Komipharm International Co., Ltd.

041960
Clasificación en acciones #13768
Komipharm International Co., Ltd. is a South Korean biopharmaceutical firm... Komipharm International Co., Ltd. is a South Korean biopharmaceutical firm specializing in the research, development, and production of veterinary pharmaceuticals and animal vaccines. Their extensive portfolio features vaccines designed for livestock like swine, cattle, and poultry, as well as companion animals such as canines. Complementing these, they offer antibiotics, disinfectants, and bio-fertilizers, in addition to providing clinical laboratory services. The company is also expanding its focus to human health, with ongoing development of anticancer drugs and pain management agents.
Precio por acción
$6.44
Capitalización bursátil
$462.75M
Cambio (1 día)
0.54%
Cambio (1 año)
49.78%
País
KR
Comercio Komipharm International Co., Ltd. (041960)

Categoría

Healthcare
Ganancias de Komipharm International Co., Ltd. (041960)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Komipharm International Co., Ltd., gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Komipharm International Co., Ltd. desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
$992.42M -
HK